Trial Profile
Evaluation of the Pharmacokinetics, Safety and Tolerability of a Single Dose of GLPG2737 Administered as Oral Suspension in Male Subjects With Cystic Fibrosis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs GLPG 2737 (Primary)
- Indications Cystic fibrosis
- Focus Pharmacokinetics
- Sponsors Galapagos NV
- 07 Mar 2018 New trial record